Abstract
In this issue of Blood, Treon and colleagues provide strong evidence that mutations in MYD88 and CXCR4 dictate clinical presentation and survival in Waldenström macroglobulinemia (WM). © 2014 by The American Society of Hematology.
Cite
CITATION STYLE
APA
Lenz, G. (2014, May 1). Waldenström macroglobulinemia: Genetics dictates clinical course. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2014-03-558973
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free